{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T18:16:18Z","timestamp":1777313778266,"version":"3.51.4"},"reference-count":56,"publisher":"Pharmaceutical Society of Japan","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2016]]},"DOI":"10.1248\/bpb.b16-00341","type":"journal-article","created":{"date-parts":[[2016,10,31]],"date-time":"2016-10-31T18:08:34Z","timestamp":1477937314000},"page":"1809-1814","source":"Crossref","is-referenced-by-count":4,"title":["Mechanism for Increased Expression of UGT2B in the Liver of Mice with Neuropathic Pain"],"prefix":"10.1248","volume":"39","author":[{"given":"Mitsumasa","family":"Kaneta","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacokinetics, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Ochiai","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacokinetics, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Nagae","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacokinetics, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Suto","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacokinetics, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Hanagata","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacokinetics, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruka","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacokinetics, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Kitaoka","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacokinetics, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo","family":"Hatogai","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacokinetics, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutomo","family":"Ikarashi","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacokinetics, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Sugiyama","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacokinetics, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Kiguchi N, Maeda T, Kobayashi Y, Fukazawa Y, Kishioka S. Macrophage inflammatory protein-1alpha mediates the development of neuropathic pain following peripheral nerve injury through interleukin-1beta up-regulation. Pain<\/i>, 149<\/b>, 305\u2013315 (2010).","DOI":"10.1016\/j.pain.2010.02.025"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Saika F, Kiguchi N, Kobayashi Y, Fukazawa Y, Kishioka S. CC-chemokine ligand 4\/macrophage inflammatory protein-1beta participates in the induction of neuropathic pain after peripheral nerve injury. Eur. J. Pain<\/i>, 16<\/b>, 1271\u20131280 (2012).","DOI":"10.1002\/j.1532-2149.2012.00146.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Kiguchi N, Kobayashi Y, Maeda T, Saika F, Kishioka S. CC-chemokine MIP-1alpha in the spinal cord contributes to nerve injury-induced neuropathic pain. Neurosci. Lett.<\/i>, 484<\/b>, 17\u201321 (2010).","DOI":"10.1016\/j.neulet.2010.07.085"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Zhao CM, Guo RX, Hu F, Meng JL, Mo LQ, Chen PX, Liao XX, Cui Y, Feng JQ. Spinal MCP-1 contributes to the development of morphine antinociceptive tolerance in rats. Am. J. Med. Sci.<\/i>, 344<\/b>, 473\u2013479 (2012).","DOI":"10.1097\/MAJ.0b013e31826a82ce"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Hervera A, Leanez S, Negrete R, Motterlini R, Pol O. Carbon monoxide reduces neuropathic pain and spinal microglial activation by inhibiting nitric oxide synthesis in mice. PLoS ONE<\/i>, 7<\/b>, e43693 (2012).","DOI":"10.1371\/journal.pone.0043693"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Kim D, Kim MA, Cho IH, Kim MS, Lee S, Jo EK, Choi SY, Park K, Kim JS, Akira S, Na HS, Oh SB, Lee SJ. A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity. J. Biol. Chem.<\/i>, 282<\/b>, 14975\u201314983 (2007).","DOI":"10.1074\/jbc.M607277200"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Kuboyama K, Tsuda M, Tsutsui M, Toyohara Y, Tozaki-Saitoh H, Shimokawa H, Yanagihara N, Inoue K. Reduced spinal microglial activation and neuropathic pain after nerve injury in mice lacking all three nitric oxide synthases. Mol. Pain<\/i>, 7<\/b>, 50 (2011).","DOI":"10.1186\/1744-8069-7-50"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Narita M, Yoshida T, Nakajima M, Narita M, Miyatake M, Takagi T, Yajima Y, Suzuki T. Direct evidence for spinal cord microglia in the development of a neuropathic pain-like state in mice. J. Neurochem.<\/i>, 97<\/b>, 1337\u20131348 (2006).","DOI":"10.1111\/j.1471-4159.2006.03808.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Tsuda M, Masuda T, Kitano J, Shimoyama H, Tozaki-Saitoh H, Inoue K. IFN-gamma receptor signaling mediates spinal microglia activation driving neuropathic pain. Proc. Natl. Acad. Sci. U.S.A.<\/i>, 106<\/b>, 8032\u20138037 (2009).","DOI":"10.1073\/pnas.0810420106"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Beggs S, Trang T, Salter MW. P2X4R+ microglia drive neuropathic pain. Nat. Neurosci.<\/i>, 15<\/b>, 1068\u20131073 (2012).","DOI":"10.1038\/nn.3155"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Biber K, Tsuda M, Tozaki-Saitoh H, Tsukamoto K, Toyomitsu E, Masuda T, Boddeke H, Inoue K. Neuronal CCL21 up-regulates microglia P2X4 expression and initiates neuropathic pain development. EMBO J.<\/i>, 30<\/b>, 1864\u20131873 (2011).","DOI":"10.1038\/emboj.2011.89"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Tsuda M, Shigemoto-Mogami Y, Koizumi S, Mizokoshi A, Kohsaka S, Salter MW, Inoue K. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature<\/i>, 424<\/b>, 778\u2013783 (2003).","DOI":"10.1038\/nature01786"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Trang T, Beggs S, Wan X, Salter MW. P2X4-receptor-mediated synthesis and release of brain-derived neurotrophic factor in microglia is dependent on calcium and p38-mitogen-activated protein kinase activation. J. Neurosci.<\/i>, 29<\/b>, 3518\u20133528 (2009).","DOI":"10.1523\/JNEUROSCI.5714-08.2009"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Yajima Y, Narita M, Usui A, Kaneko C, Miyatake M, Narita M, Yamaguchi T, Tamaki H, Wachi H, Seyama Y, Suzuki T. Direct evidence for the involvement of brain-derived neurotrophic factor in the development of a neuropathic pain-like state in mice. J. Neurochem.<\/i>, 93<\/b>, 584\u2013594 (2005).","DOI":"10.1111\/j.1471-4159.2005.03045.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Coull JA, Beggs S, Boudreau D, Boivin D, Tsuda M, Inoue K, Gravel C, Salter MW, De Koninck Y. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature<\/i>, 438<\/b>, 1017\u20131021 (2005).","DOI":"10.1038\/nature04223"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Masuda T, Tsuda M, Yoshinaga R, Tozaki-Saitoh H, Ozato K, Tamura T, Inoue K. IRF8 is a critical transcription factor for transforming microglia into a reactive phenotype. Cell Reports<\/i>, 1<\/b>, 334\u2013340 (2012).","DOI":"10.1016\/j.celrep.2012.02.014"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Deumens R, Jaken RJ, Knaepen L, van der Meulen I, Joosten EA. Inverse relation between intensity of GFAP expression in the substantia gelatinosa and degree of chronic mechanical allodynia. Neurosci. Lett.<\/i>, 452<\/b>, 101\u2013105 (2009).","DOI":"10.1016\/j.neulet.2008.12.062"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Mika J, Osikowicz M, Rojewska E, Korostynski M, Wawrzczak-Bargiela A, Przewlocki R, Przewlocka B. Differential activation of spinal microglial and astroglial cells in a mouse model of peripheral neuropathic pain. Eur. J. Pharmacol.<\/i>, 623<\/b>, 65\u201372 (2009).","DOI":"10.1016\/j.ejphar.2009.09.030"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Miyoshi K, Obata K, Kondo T, Okamura H, Noguchi K. Interleukin-18-mediated microglia\/astrocyte interaction in the spinal cord enhances neuropathic pain processing after nerve injury. J. Neurosci.<\/i>, 28<\/b>, 12775\u201312787 (2008).","DOI":"10.1523\/JNEUROSCI.3512-08.2008"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Romero-Sandoval A, Chai N, Nutile-McMenemy N, Deleo JA. A comparison of spinal Iba1 and GFAP expression in rodent models of acute and chronic pain. Brain Res.<\/i>, 1219<\/b>, 116\u2013126 (2008).","DOI":"10.1016\/j.brainres.2008.05.004"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Kawasaki Y, Xu ZZ, Wang X, Park JY, Zhuang ZY, Tan PH, Gao YJ, Roy K, Corfas G, Lo EH, Ji RR. Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat. Med.<\/i>, 14<\/b>, 331\u2013336 (2008).","DOI":"10.1038\/nm1723"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Mika J, Zychowska M, Popiolek-Barczyk K, Rojewska E, Przewlocka B. Importance of glial activation in neuropathic pain. Eur. J. Pharmacol.<\/i>, 716<\/b>, 106\u2013119 (2013).","DOI":"10.1016\/j.ejphar.2013.01.072"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Shibata K, Sugawara T, Fujishita K, Shinozaki Y, Matsukawa T, Suzuki T, Koizumi S. The astrocyte-targeted therapy by Bushi for the neuropathic pain in mice. PLoS ONE<\/i>, 6<\/b>, e23510 (2011).","DOI":"10.1371\/journal.pone.0023510"},{"key":"24","unstructured":"24) Tsuda M, Kohro Y, Yano T, Tsujikawa T, Kitano J, Tozaki-Saitoh H, Koyanagi S, Ohdo S, Ji RR, Salter MW, Inoue K. JAK-STAT3 pathway regulates spinal astrocyte proliferation and neuropathic pain maintenance in rats. Brain: A Journal of Neurology<\/i>, 134<\/b>, 1127\u20131139 (2011)."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Vallejo R, Tilley DM, Vogel L, Benyamin R. The role of glia and the immune system in the development and maintenance of neuropathic pain. Pain Practice: The Official Journal of World Institute of Pain<\/i>, 10<\/b>, 167\u2013184 (2010).","DOI":"10.1111\/j.1533-2500.2010.00367.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Cahill CM, Xue L, Grenier P, Magnussen C, Lecour S, Olmstead MC. Changes in morphine reward in a model of neuropathic pain. Behav. Pharmacol.<\/i>, 24<\/b>, 207\u2013213 (2013).","DOI":"10.1097\/FBP.0b013e3283618ac8"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Matsuzawa-Yanagida K, Narita M, Nakajima M, Kuzumaki N, Niikura K, Nozaki H, Takagi T, Tamai E, Hareyama N, Terada M, Yamazaki M, Suzuki T. Usefulness of antidepressants for improving the neuropathic pain-like state and pain-induced anxiety through actions at different brain sites. Neuropsychopharmacology<\/i>, 33<\/b>, 1952\u20131965 (2008).","DOI":"10.1038\/sj.npp.1301590"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Odo M, Koh K, Takada T, Yamashita A, Narita M, Kuzumaki N, Ikegami D, Sakai H, Iseki M, Inada E, Narita M. Changes in circadian rhythm for mRNA expression of melatonin 1A and 1B receptors in the hypothalamus under a neuropathic pain-like state. Synapse<\/i>, 68<\/b>, 153\u2013158 (2014).","DOI":"10.1002\/syn.21728"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Ochiai W, Kaneta M, Nagae M, Yuzuhara A, Li X, Suzuki H, Hanagata M, Kitaoka S, Suto W, Kusunoki Y, Kon R, Miyashita K, Masukawa D, Ikarashi N, Narita M, Suzuki T, Sugiyama K. Mice with neuropathic pain exhibit morphine tolerance due to a decrease in the morphine concentration in the brain. Eur. J. Pharm. Sci.<\/i>, 92<\/b>, 298\u2013304 (2016).","DOI":"10.1016\/j.ejps.2016.03.019"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Buckley DB, Klaassen CD. Induction of mouse UDP-glucuronosyltransferase mRNA expression in liver and intestine by activators of aryl-hydrocarbon receptor, constitutive androstane receptor, pregnane X receptor, peroxisome proliferator-activated receptor alpha, and nuclear factor erythroid 2-related factor 2. Drug Metab. Dispos.<\/i>, 37<\/b>, 847\u2013856 (2009).","DOI":"10.1124\/dmd.108.024190"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Shelby MK, Klaassen CD. Induction of rat UDP-glucuronosyltransferases in liver and duodenum by microsomal enzyme inducers that activate various transcriptional pathways. Drug Metab. Dispos.<\/i>, 34<\/b>, 1772\u20131778 (2006).","DOI":"10.1124\/dmd.106.010397"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Tolson AH, Wang H. Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR. Adv. Drug Deliv. Rev.<\/i>, 62<\/b>, 1238\u20131249 (2010).","DOI":"10.1016\/j.addr.2010.08.006"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Hernandez JP, Mota LC, Huang W, Moore DD, Baldwin WS. Sexually dimorphic regulation and induction of P450s by the constitutive androstane receptor (CAR). Toxicology<\/i>, 256<\/b>, 53\u201364 (2009).","DOI":"10.1016\/j.tox.2008.11.002"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Honkakoski P, Zelko I, Sueyoshi T, Negishi M. The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene. Mol. Cell. Biol.<\/i>, 18<\/b>, 5652\u20135658 (1998).","DOI":"10.1128\/MCB.18.10.5652"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Xie W, Barwick JL, Simon CM, Pierce AM, Safe S, Blumberg B, Guzelian PS, Evans RM. Reciprocal activation of xenobiotic response genes by nuclear receptors SXR\/PXR and CAR. Genes Dev.<\/i>, 14<\/b>, 3014\u20133023 (2000).","DOI":"10.1101\/gad.846800"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Guo GL, Lambert G, Negishi M, Ward JM, Brewer HB Jr, Kliewer SA, Gonzalez FJ, Sinal CJ. Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity. J. Biol. Chem.<\/i>, 278<\/b>, 45062\u201345071 (2003).","DOI":"10.1074\/jbc.M307145200"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Kast HR, Goodwin B, Tarr PT, Jones SA, Anisfeld AM, Stoltz CM, Tontonoz P, Kliewer S, Willson TM, Edwards PA. Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J. Biol. Chem.<\/i>, 277<\/b>, 2908\u20132915 (2002).","DOI":"10.1074\/jbc.M109326200"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Hartley DP, Dai X, He YD, Carlini EJ, Wang B, Huskey SE, Ulrich RG, Rushmore TH, Evers R, Evans DC. Activators of the rat pregnane X receptor differentially modulate hepatic and intestinal gene expression. Mol. Pharmacol.<\/i>, 65<\/b>, 1159\u20131171 (2004).","DOI":"10.1124\/mol.65.5.1159"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Ratajewski M, Walczak-Drzewiecka A, Salkowska A, Dastych J. Aflatoxins upregulate CYP3A4 mRNA expression in a process that involves the PXR transcription factor. Toxicol. Lett.<\/i>, 205<\/b>, 146\u2013153 (2011).","DOI":"10.1016\/j.toxlet.2011.05.1034"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, Kliewer SA. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J. Clin. Invest.<\/i>, 102<\/b>, 1016\u20131023 (1998).","DOI":"10.1172\/JCI3703"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Bertilsson G, Heidrich J, Svensson K, Asman M, Jendeberg L, Sydow-Backman M, Ohlsson R, Postlind H, Blomquist P, Berkenstam A. Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. Proc. Natl. Acad. Sci. U.S.A.<\/i>, 95<\/b>, 12208\u201312213 (1998).","DOI":"10.1073\/pnas.95.21.12208"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Kliewer SA, Moore JT, Wade L, Staudinger JL, Watson MA, Jones SA, McKee DD, Oliver BB, Willson TM, Zetterstrom RH, Perlmann T, Lehmann JM. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell<\/i>, 92<\/b>, 73\u201382 (1998).","DOI":"10.1016\/S0092-8674(00)80900-9"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Chen YH, Wang JP, Wang H, Sun MF, Wei LZ, Wei W, Xu DX. Lipopolysaccharide treatment downregulates the expression of the pregnane X receptor, cyp3a11 and mdr1a genes in mouse placenta. Toxicology<\/i>, 211<\/b>, 242\u2013252 (2005).","DOI":"10.1016\/j.tox.2005.03.011"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Geick A, Eichelbaum M, Burk O. Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J. Biol. Chem.<\/i>, 276<\/b>, 14581\u201314587 (2001).","DOI":"10.1074\/jbc.M010173200"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Maglich JM, Stoltz CM, Goodwin B, Hawkins-Brown D, Moore JT, Kliewer SA. Nuclear pregnane X receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol. Pharmacol.<\/i>, 62<\/b>, 638\u2013646 (2002).","DOI":"10.1124\/mol.62.3.638"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Moalem G, Tracey DJ. Immune and inflammatory mechanisms in neuropathic pain. Brain Res. Rev.<\/i>, 51<\/b>, 240\u2013264 (2006).","DOI":"10.1016\/j.brainresrev.2005.11.004"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Scholz J, Woolf CJ. The neuropathic pain triad: neurons, immune cells and glia. Nat. Neurosci.<\/i>, 10<\/b>, 1361\u20131368 (2007).","DOI":"10.1038\/nn1992"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Gu X, Ke S, Liu D, Sheng T, Thomas PE, Rabson AB, Gallo MA, Xie W, Tian Y. Role of NF-kappaB in regulation of PXR-mediated gene expression: a mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents. J. Biol. Chem.<\/i>, 281<\/b>, 17882\u201317889 (2006).","DOI":"10.1074\/jbc.M601302200"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Pascussi JM, Vilarem MJ. Inflammation and drug metabolism: NF-kappaB and the CAR and PXR xeno-receptors. Med. Sci.<\/i> (Paris), 24<\/b>, 301\u2013305 (2008).","DOI":"10.1051\/medsci\/2008243301"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Zordoky BN, El-Kadi AO. Role of NF-kappaB in the regulation of cytochrome P450 enzymes. Curr. Drug Metab.<\/i>, 10<\/b>, 164\u2013178 (2009).","DOI":"10.2174\/138920009787522151"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Xie Y, Ke S, Ouyang N, He J, Xie W, Bedford MT, Tian Y. Epigenetic regulation of transcriptional activity of pregnane X receptor by protein arginine methyltransferase 1. J. Biol. Chem.<\/i>, 284<\/b>, 9199\u20139205 (2009).","DOI":"10.1074\/jbc.M806193200"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Velenosi TJ, Feere DA, Sohi G, Hardy DB, Urquhart BL. Decreased nuclear receptor activity and epigenetic modulation associates with down-regulation of hepatic drug-metabolizing enzymes in chronic kidney disease. FASEB J.<\/i>, 28<\/b>, 5388\u20135397 (2014).","DOI":"10.1096\/fj.14-258780"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Zhu X, Li Q, Chang R, Yang D, Song Z, Guo Q, Huang C. Curcumin alleviates neuropathic pain by inhibiting p300\/CBP histone acetyltransferase activity-regulated expression of BDNF and cox-2 in a rat model. PLoS ONE<\/i>, 9<\/b>, e91303 (2014).","DOI":"10.1371\/journal.pone.0091303"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Schuetz EG, Strom S, Yasuda K, Lecureur V, Assem M, Brimer C, Lamba J, Kim RB, Ramachandran V, Komoroski BJ, Venkataramanan R, Cai H, Sinal CJ, Gonzalez FJ, Schuetz JD. Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450. J. Biol. Chem.<\/i>, 276<\/b>, 39411\u201339418 (2001).","DOI":"10.1074\/jbc.M106340200"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Staudinger JL, Goodwin B, Jones SA, Hawkins-Brown D, MacKenzie KI, LaTour A, Liu Y, Klaassen CD, Brown KK, Reinhard J, Willson TM, Koller BH, Kliewer SA. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc. Natl. Acad. Sci. U.S.A.<\/i>, 98<\/b>, 3369\u20133374 (2001).","DOI":"10.1073\/pnas.051551698"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Scheer N, Ross J, Rode A, Zevnik B, Niehaves S, Faust N, Wolf CR. A novel panel of mouse models to evaluate the role of human pregnane X receptor and constitutive androstane receptor in drug response. J. Clin. Invest.<\/i>, 118<\/b>, 3228\u20133239 (2008).","DOI":"10.1172\/JCI35483"}],"container-title":["Biological & Pharmaceutical Bulletin","Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/39\/11\/39_b16-00341\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T22:28:41Z","timestamp":1498343321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/39\/11\/39_b16-00341\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":56,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b16-00341","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}